Close X
Attorney Spotlight

What emerging trend in shareholder litigation does Britt Latham find most interesting in his practice today?    Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Insider's Insights from the Deal Points Study

Events

March 8, 2018

Bass, Berry & Sims attorney Tatjana Paterno will present a webinar titled "Insider's Insights from the Deal Points Study" on March 8, 2018, from 1:00 p.m. - 2:30 p.m. EST. Other panelists will include:

  • Jessica Pearlman (chair), K&L Gates LLP
  • Edward Deibert, Arnold & Porter
  • Ashley Hess, Baker & Hostetler LLP
  • Lisa Hedrick, Hirschler Fleischer
  • Michael Kendall, Goodwin Procter LLP
  • Kevin Kyte, Stikeman Elliott LLP
  • Cindy Lin, King & Spalding LLP
  • Joanna Lin, McDermott Will & Emery LLP
  • Chris Scheurer, McGuireWoods LLP
  • Isabella Wezdecki, Johnson & Johnson

The Deal Points Studies of the Mergers & Acquisitions Committee have gained wide recognition as the gold standard for market metrics of key negotiated legal issues in M&A agreements. During the webinar, the panel will discuss insights from issue group leaders of the recently-released 2017 version of the Committee's flagship Private Target Deal Points Study. 

The webinar is eligible for 1.50 General CLE Credit Hours. For more information and registration, visit the ABA website


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.